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Objective: To identify studies using Multi Criteria Decision Analysis (MCDA) software tools to support health 2 
prioritisation processes and to describe the technical capabilities of the MCDA software tools identified. 3 
Methods: First, a systematic literature review was conducted in Medline, Embase, Web of Science, Econlit 4 
and Cochrane databases in July 2019, to identify studies that have used MCDA software for priority setting 5 
in health-related problems. Second, the MCDA software tools found in the review were downloaded (full 6 
versions, where freely available, and trial versions otherwise) and tested to extract their key technical 7 
characteristics.  8 
Results: Nine studies were included, from which seven different software: 1000minds, M-MACBETH, Socio 9 
Technical Allocation of Resources (STAR), Strategic Multi-Attribute Ranking Tool (SMART), Visual 10 
PROMETHEE, EVIDEM and Prioritisation Framework were identified. These software tools differed in terms 11 
of the operating systems (including web interface), MCDA technique(s) available for use, visualization 12 
features and the capability to perform Value for Money (VfM) and sensitivity analyses. 13 
Conclusions: The use of MCDA software in prioritization processes has a number of advantages such as 14 
inclusion of several types of stakeholders, ability to analyse a greater number of alternatives and criteria and 15 
perform real time sensitivity analyses. Proprietary software (i.e. software with licensing fees) seemed to 16 
have more features compared to freely available software. However, this field is still developing, with only a 17 
few studies where MCDA software was used to support health priority setting and opportunity costs not 18 
explicitly captured in many software.  19 
  20 
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Key points for Decision Makers 1 
There are many MCDA software tools available to support priority setting in health care, which differ in 2 
terms of the operating systems (including web interface), MCDA technique(s) available for use, visualization 3 
features and the capability to perform Value for Money (VfM) and sensitivity analyses. 4 
Proprietary software (i.e. software with licensing fees) seem to have more features compared to freely 5 
available software.  6 
However, this field is still developing, with only a few studies where MCDA software was used to support 7 
health priority setting, and costs and considerations of opportunity costs not explicitly captured in many 8 
software.  9 
 10 
  11 
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1. Introduction 1 
Given the scarce health care resources, increasing number of new health technologies (many of them of 2 
high cost) and the conflicting objectives of stakeholders, priority setting in healthcare is not only necessary, 3 
but also one of the most complex and sensitive tasks [1,2]. Consequently, many countries have decided to 4 
establish systematic and rational mechanisms, with explicit criteria and a structured institutional framework 5 
for health technologies prioritisation [3–9].  6 
Multi criteria decision analysis (MCDA) has been used as a transparent, participatory framework for 7 
supporting decision making and policy setting in healthcare  [8,10,11]. The benefits of MCDA approaches 8 
include supporting stakeholders through the process, aligning investments in health technologies with their 9 
preferences/needs and providing legitimacy to the decision-making process [12]. MCDA process broadly 10 
involves problem structuring (i.e. selection of participants, alternatives and criteria); MCDA modelling (i.e. 11 
weighting, scoring and aggregation); and decision-making (i.e. interpretation of results and decision-making) 12 
[13]. 13 
Reviews on the use of MCDA in healthcare decision-making [14,15] suggested that most MCDA studies have 14 
typically been pilot studies or bespoke analysis (i.e. without the use of multi-criteria software). The MCDA 15 
processes are usually performed using paper forms or templates filled out manually or using spreadsheets 16 
to collect the preferences of the participants [16,17]. Most of the MCDA studies did not use the 17 
computational tools available to address these problems. Given priority setting in healthcare is often 18 
associated with a large number of interventions along with multiple criteria and stakeholders, the use of 19 
manual MCDA approaches has several limitations including cognitive burden, implementation difficulties, 20 
and the inability to perform sensitivity and scenario analyses.  21 
There is a range of MCDA software available that can support priority setting processes [18]. The benefits of 22 
using MCDA software include facilitating data manipulation, reducing transcription errors, allowing the 23 
immediate feedback of the results, and the capability to allow multiple simultaneous users. However, 24 
despite the availability of MCDA software, their use in the health care field is still in its infancy [19]. 25 
This study aims to review systematically studies that used MCDA software to support priority setting in 26 
healthcare and to summarise the technical characteristics of the MCDA software identified in the review. 27 
The potential beneficiaries of this review include the decision makers considering using MCDA software to 28 
support priority setting process in health care; researchers that are interested in facilitating MCDA studies 29 
to support health care priority setting; and developers of MCDA software to support health care priority 30 
setting 31 
The rest of the article is structured as follows. Section 2 describes the methods of the systematic review 32 
and the methods to identify the software and describe the key features. Section 3 presents the results of 33 
the systematic review and the technical capabilities of the MCDA software tools identified. Section 4 34 
presents the discussion of the findings along with considerations for the use of MCDA tools to support 35 
prioritisation in health care.  36 
 37 
2. Methods 38 
 39 
2.1 Systematic review of studies using MCDA software for priority setting 40 
 41 
The aim of the review was to identify studies that have used MCDA software tools to support decision-42 
making processes in the context of health technologies prioritisation. This section provides details about the 43 
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methods of the systematic review including the literature searches, study selection and data extraction and 1 
analysis.   2 
 3 
2.1.1 Literature Searches 4 
Searches were carried out in the relevant academic databases (Medline, Embase, Web of Science, Econlit 5 
and Cochrane), reference lists and grey literature in Google Scholar, in July 2019. The search terms related 6 
to “software”, “prioritization processes” and “health”. Appendix 1 presents the search strategies for each 7 
database. The reference lists of the included studies were also searched to identify relevant studies. 8 
2.1.2 Study selection 9 
The papers considered for inclusion were those that implemented or adopted MCDA software for priority 10 
setting in health-related problems. Conversely, studies were excluded if they did not use MCDA, did not 11 
involve prioritization problems or if the prioritization was not related to health, or if they used software 12 
but not directly to support the MCDA process (for example, statistical packages). 13 
 14 
Fig 1 PRISMA (preferred reporting items for systematic reviews and meta-analyses) diagram 15 
2.1.3 Data Extraction and Analysis 16 
Data was extracted from the selected articles including: the year and place of the study, the aims and 17 
objectives of study (i.e. what is prioritized), the alternatives evaluated, the participants (i.e. the respondents 18 
of the weighting and scoring processes) and the criteria used in the analysis. Information about MCDA tool, 19 
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the MCDA techniques used (i.e., the weighting and scoring methods) and the software description 1 
presented in the included studies was also extracted. 2 
 3 
2.2 Description of MCDA software identified from the systematic review 4 
 5 
Each software tool found in the studies included in the systematic review was downloaded (latest version 6 
available to December 2018), installed and tested to identify the main technical features including the 7 
general features associated with MCDA software as well as specific considerations to health priority setting. 8 
Full versions of the MCDA software, where freely available, and trial versions otherwise were downloaded. 9 
Based on previous studies [20,21], the following general characteristics were extracted including creation 10 
date, country, operating system required, web interface, available versions and prices. Technical aspects 11 
were also extracted including the type of MCDA technique; visualization (graphical interface for the inputs 12 
and results); sensitivity analysis (evaluation of the uncertainty impact on the final ranking); cluster analysis 13 
(evaluation of possible user groups, criteria or technologies); and availability of tutorials and/or manuals.  14 
Moreover, considerations specifically relating to healthcare prioritisation were extracted such as whether 15 
the tool has capability to perform Value for Money (VfM) [22,23], to take into account the issues associated 16 
with the consideration of costs and opportunity costs in health care priority setting [19,24]. 17 
 18 
3. Results 19 
 20 
3.1 Results of the systematic review of studies using MCDA software for priority setting 21 
 22 
3.1.1 Literature Searches and sifting 23 
A total of 5007 articles were identified in the searches, of which 2594 were duplicates. After the screening 24 
for titles and abstracts taking into account the inclusion and exclusion criteria, 45 papers were selected for 25 
full-text assessment.  36 articles were discarded, mainly because they were not related to health care (e.g. 26 
related to prioritization in veterinary medicine), or because they did not carry out a prioritization process 27 
or did not use an MCDA software tool. The results of the sifting are presented as PRISMA (Preferred 28 
Reporting Items for Systematic reviews and Meta-Analyses) diagram in Figure 1. 29 
3.1.2 Data Extraction 30 
An overview of the nine included studies is presented in Table 1. The studies were from six countries 31 
(Canada, Colombia, Israel, New Zealand, United Kingdom [UK] and United States of America [USA]), in the 32 
period between 2012 and 2016. Three studies, by Madhavan et al [25–27], related to the same project. 33 
Table 1 presents summary of the data extracted, including the objective of study, the alternatives 34 
evaluated, the participants, the criteria, the MCDA software and the MCDA techniques used. These data 35 
are described in more detail below. 36 
All the case studies had the purpose of ranking health technologies, two studies ranked a group of 37 
technologies made up of medicines and medical devices [28,29]; two studies prioritized vector-borne and 38 
zoonotic diseases  [7,10]. The study by Airoldi et al. was focused on health programs [22]; while Castro et 39 
al. and Madhavan et al. carried out a prioritization of medicines and vaccines, respectively [25–27,30]. 40 
The participants in the MCDA were key stakeholders such as professionals or health experts, patients, 41 
providers, officials in the public health sector, representatives of patient organizations and academics. The 42 
general public was included as participants in some of the studies [22,28]. The number of participants had 43 
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a large dispersion from seven in Castro et al. [30] to more than 300 people in the study of Sullivan et al. 1 
[29]. Of the nine studies, only two had less than 50 participants. 2 
The criteria used in the analyses mainly related to the following categories: health benefits (lives saved, 3 
life-prolongation benefit, quality-of-life gains, health before treatment, individual benefits), public health 4 
(health inequality reduction, social impact, lifestyle, social benefits, public health interest), economic (total 5 
costs, cost-effectiveness of intervention), environmental (influence of climate change) and epidemiological 6 
or demographical factors (number of potential patients, patient age). 7 
Seven different software tools were identified : 1000minds [28,29], M-MACBETH [7], Socio Technical 8 
Allocation of Resources (STAR) [22], Strategic Multi-Attribute Ranking Tool (SMART) [25–27], Visual 9 
PROMETHEE [10], EVIDEM [30], and the Prioritisation Framework [31] developed by the Public Health 10 
England (PHE). Six studies related to MCDA software tools developed specifically to deal with specific 11 
problems of prioritization in health [22,25–27,30,31]. The other studies used existing MCDA 12 
frameworks/software for addressing health care prioritisation problems [7, 28, 29].  13 
Different MCDA techniques were used in the software. Six techniques were identified: Potentially all 14 
pairwise rankings of all possible alternatives (PAPRIKA) [28,29], Measuring Attractiveness by a Categorical 15 
Based Evaluation Technique (MACBETH) [7], Additive version of multi-attribute utility method (MAUT) [25–16 
27], Program budgeting and marginal analysis (PBMA) and Simple Additive Weighting (SAW) [22], 17 
Preference Ranking Organization Method for Enrichment Evaluations (PROMETHEE) [10] and SAW [30]. 18 
In general, the studies lacked a detailed description of the software characteristics. Only, three studies by 19 
Madhavan et al. [25–27] provided details regarding software design and implementation. Airoldi et al., 20 
Castro et al. and Sullivan et al. did not describe the features of the software tools used [22,29,30]. Golan et 21 
al., Cox et al. and Hongoh et al. only mentioned the version and website of the applications [7,10,28]. As 22 
such, each software was downloaded and tested to identify and describe their key features as presented in 23 
the next section. 24 
8 
 
Table 1 Studies included in the review 25 
Paper Golan et al. [28] Cox et al. [7] Airoldi et al. [22] Madhavan et al. 
[25–27] 
Hongoh et al. 
[10] 
Castro et al. [30] Sullivan et al. 
[29] 
Year 2012 2013 2013 2012 – 2015 2016 2013 2016 
Country Israel - New 
Zealand 
Canada UK USA Canada Colombia New Zealand 
Description To present "The 
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PAPRIKA Potentially all pairwise rankings of all possible alternatives, , MACBETH Measuring Attractiveness by a Categorical Based Evaluation Technique, PBMA Program 26 
Budgeting and Marginal Analysis, MAUT Multi-Attribute Utility Method, PROMETHEE Preference Ranking Organization Method for Enrichment Evaluations, SAW Simple 27 




3.2 Results of the description of MCDA software 1 
 2 
The seven software identified from the systematic review were downloaded. Full versions were obtained 3 
for four software (SMART, STAR, EVIDEM, Prioritisation Framework) as these were freely available and trial 4 
versions were obtained for the other three software (1000minds, Visual PROMETHEE, M-MACBETH), as 5 
these required payment for accessing full versions. An overview of all the software is presented in Table 2. 6 
These software varied in terms of operating systems (including web interface), MCDA technique(s), 7 
visualization, and the capability to perform VfM and sensitivity analyses.  8 
Three software were implemented in MS Excel (STAR, EVIDEM, Prioritisation Framework) while the other 9 
four were developed as stand-alone software (1000Minds, SMART, Visual PROMETHEE, M-MACBETH). 10 
1000minds is developed as a web application, which allows remote participation and the access of results in 11 
real time. SMART was developed in MATLAB. The details of the underlying programming language of Visual 12 
PROMETHEE and M-MACBETH were not clear.  13 
Each software implemented a single MCDA method. M-MACBETH uses pairwise comparison with interval 14 
scales [32]. 1000minds uses PAPRIKA (Potentially all pairwise rankings of all possible alternatives), which 15 
involves pairwise rankings of undominated pairs [33]. Visual PROMETHEE uses the PROMETHEE technique, 16 
an outranking approach based on thresholds of preference and indifference [34]. SMART software is based 17 
on MAUT [35], where the final ranking of vaccines is generated through a weighted average of the 18 
attributes (quantitative or qualitative) chosen by the users; the process to weight the attributes is carried 19 
out through the “swing weighting” method. STAR application implemented programme budgeting and 20 
marginal analysis (PBMA), in which a marginal analysis of the benefits (based on SAW) and the costs added 21 
of new interventions is carried out comparing the lost benefits by a possible disinvestment [36]. Finally, in 22 
EVIDEM a simple linear aggregation model is applied, using a list of criteria and pre-established rating scales 23 
for weights and scores [37]. 24 
In relation to visual interface, all software have modules for the inclusion of alternatives, criteria (EVIDEM 25 
and SMART with a predefined list of criteria), elicitation of weights and scores; as well as a final ranking of 26 
the interventions. Software tools that were developed as proprietary software (1000minds, SMART 27 
Vaccines, Visual PROMETHEE, M-MACBETH) showed advantages in terms of accessibility and by generating 28 
additional graphs and analyses. For example, Visual PROMETHEE includes GAIA plane, which is a principal 29 
component analysis on the MCDA allowing the visualisation of multidimensional problems. 30 
Deterministic sensitivity analysis was implemented in 1000minds, Visual PROMETHEE, and M-MACBETH 31 
(e.g. allowing modifying the weights to analyse their impact in the final ranking). Prioritisation Framework 32 
has the capability to perform scenario analysis comparing different budgets. 1000minds and Visual 33 
PROMETHEE also have the capability to perform cluster analysis; the former allows the grouping of 34 
stakeholders and the latter the analysis of subgroups of criteria. 35 
Two of the identified software allow VfM analysis: Golan et al. implemented it in 1000minds allowing the 36 
comparison of the PAPRIKA ranking with the costs of the alternatives, evidence quality and other factors 37 
[28]. In STAR toolkit, the VfM analysis is carried out in a graph where the benefit and the cost of each 38 
alternative are represented by means of right triangles [22]. 39 
Lastly, all the software tools have support or help material. Table 2 shows the information available from 40 
manuals, tutorials and guides for each program, including website links to the help material for each of 41 
these software (last accessed July 2019). Of the 9 included software, XXx software just included manuals as 42 
pdf or word documents, xxx software had an interactive online help and some had help function inbuilt 43 
within the software itself.44 
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Table 2 Overview of the MCDA software tools found in the review 









Creation date 2003 2012 – 2015 2010 2013 Early 90’s  2006 2018 





with a web 
browser. 
Windows (XP or 
above) 
Windows (XP or 
above) 
Compatible with 
Excel 97-2007  
Windows (XP or 
above) 
Excel 2003 and 
later versions 
Excel 2003 and 
later versions 

















A table where the 
alternatives, 
criteria, weights 
and their values 
are entered. 








Value tree where 
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A table in excel 
where the score 
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bar graph, radar 






bubble chart (four 
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etc. 
Chart benefit per 
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Summary tables of 




Value for Money 
(VfM) 
A bubble chart is 
used to represent 
VfM, the y-axis 
shows the benefit 
of each alternative 
in terms of a 
"PAPRIKA total 
score" and the x-
axis illustrates the 
No No 
VfM is represented 
in right triangles 
whose legs 
correspond to the 
benefits and costs 
of the 
intervention. With 
a greater gradient, 
the VfM is better. 
No No No 
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cost of each 
alternative. 
Additionally, the 
size and color of 
the bubbles reflect 
factors such as 
risk, evidence 
quality, strategic 
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alternative 
No 
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4. Discussion 1 
This article set out to provide a systematic review of the studies using MCDA software tools to support 2 
health prioritisation processes and to examine the MCDA software used for health care priority setting.  3 
Whilst previous reviews on the use of MCDA in healthcare decision-making identified studies related to 4 
priority setting, they did not focus specifically on those that used MCDA software. For instance, Weernink et 5 
al. searched for studies that used a preference elicitation method in the context of Health Technology 6 
Assessment (HTA) and  found only three studies that used MCDA for priority setting [38]. In the Marsh et al. 7 
review [14], of the 40 MCDA studies applied in the assessment of value of healthcare Interventions, 22 8 
studies related to prioritization of interventions . Adunlin et al. also searched for publication patterns and 9 
topics where MCDA has been used and found eight publications on priority setting (12%)  [15]. These 10 
reviews report that the majority of the included studies were bespoke analyses without the use of MCDA 11 
software.  12 
To our knowledge, there has not been a systematic review on the use of multicriteria software in health 13 
priority setting and our study represents the first. Our review found only a few studies that used MCDA 14 
software in healthcare decision-making. Nine studies were identified in Canada, New Zealand, UK, USA, 15 
Israel, and Colombia which looked at the prioritisation of medicines, procedures, medical devices, diseases 16 
and/or health programs at a national level. From these nine studies, seven software were identified. 17 
EVIDEM, STAR, SMART and Prioritisation Framework provide free access to their full version, which were 18 
developed specifically to assess healthcare decisions. M-MACBETH, 1000minds and Visual PROMETHEE are 19 
general-purpose commercial software that have also been implemented in other fields [39]. In all the MCDA 20 
software identified, the inputs are used to define aspects such as criteria, weights, alternatives and scores; 21 
and the MCDA tools integrate these data, producing outputs such as graphs, tables, and reports.  22 
The advantages suggested by the use of software in the studies include greater participation of 23 
stakeholders, capability to include higher number of criteria, the ability to perform sensitivity/scenario 24 
analyses and visual presentation of the results. Whilst the other advantages are useful, we suggest caution 25 
against using higher number of criteria and to some extent, the use of greater number of stakeholders as 26 
well. 27 
In general, the use of MCDA software allow greater participation from stakeholders; ranging between 7 and 28 
322 participants in those studies we identified in the review. The automatic generation of forms, the ability 29 
to handle large amount of information and possibility of responding through a web interface make it 30 
feasible to cater for many participants. However, appropriate caution needs to be taken to ensure that there 31 
is sufficient discussion between the stakeholders prior to preference elicitation as the true benefit of MCDA 32 
is the learning from the participatory process, not mechanistic implementation of the techniques [40]. 33 
Likewise, a higher number of decision criteria can be included in the analysis when using MCDA software. In 34 
in the studies included in our review, the number of decision criteria evaluated by the MCDA software range 35 
between 3 and 40. This is higher than the number of decision criteria reported in a previous review of MCDA 36 
studies (average of 8.2 criteria, ranging between 3 and 19), suggesting more criteria are included in studies 37 
using MCDA software compared to those using MCDA without the support of off-the-shelf software [14]. As 38 
such, caution needs to be taken to ensure that all the criteria are relevant to the problem when using the 39 
MCDA software rather than including every possible criterion. This is to avoid cognitive burden (even with 40 
the MCDA software there is substantive burden on the stakeholders for every additional criterion) and the 41 
associated risks such as the possibility of biased outputs.  42 
All the software present the information visually to support the decision making and the exploration of data 43 
in an easy and quick manner to different stakeholders at different levels [41].  Regarding graphical interface 44 
of the analysed applications, Prioritisation Framework, EVIDEM and STAR were developed on an existing 45 
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platform (MS Excel), and as such are limited in their presentation of results due to the constraints of the 1 
underlying platform (MS Excel). In contrast, the other proprietary software (i.e. 1000minds, Visual 2 
PROMETHEE and M-MACBETH), which were developed as bespoke applications, offer more variety in the 3 
graphic options for results interpretation as well as customized reports depending on the problem 4 
proposed. 5 
In our review, only M-MACBETH, 1000minds and Visual PROMETHEE allow a parametric sensitivity analysis, 6 
and the results are presented using graphs, tornado charts or stability intervals. Sensitivity analysis is 7 
considered important in allowing the decision maker explore the reasons for the discrepancies in MCDA 8 
model results with their expectations [42]. In addition to sensitivity analyses, there are other types of 9 
uncertainty: stochastic,  heterogeneous and structural uncertainty [43], which are not included in any of the 10 
MCDA software that we examined. These analyses are not always performed in multi-criteria studies in 11 
health; as reported in the review by Marsh et al.[14] where only 50% of the studies reported some type of 12 
uncertainty analysis. For health priority setting, further software or improvements in existing software is 13 
required to consider uncertainty in a robust way.  14 
Given the health care priority setting is about resource allocation, consideration of costs is necessary. 15 
However, many of the software do not consider cost aspects or budgets explicitly. VfM analysis offers a way 16 
to appraise them, contrasting overall MCDA scores with the costs of the alternatives to identify the rank 17 
order of technologies in terms of value for money (i.e. which technologies provide the most value for the 18 
least cost) [44]. In our review, only two of the identified software allow VfM analysis: 1000minds and STAR. 19 
Consideration of opportunity costs in MCDA is an important issue and has been highlighted by many 20 
researchers [19,23,45]. It is recommended that all health priority setting software should include the ability 21 
to perform VfM analyses to include an explicit consideration of costs.  22 
Our review has some limitations. Although it was carried out through a systematic procedure and consulting 23 
multiple databases, the list is unlikely to be exhaustive. Due to sensitive nature of priority setting projects at 24 
a national or local level, there may be studies that are not published in indexed journals. As such, there may 25 
be other relevant studies (and software) in the non-indexed grey literature that were not included in our 26 
review.  Furthermore, studies that did not mention priority or prioritization in their title or abstract may 27 
have been missed.  However, we performed reference checking and citation searching of the included 28 
studies to ensure the inclusion of all relevant studies that used MCDA software for priority setting in health 29 
care. 30 
The review was also limited by the information presented in the published studies and the information in 31 
the MCDA software tools. The included studies did not delve into the description of aspects such as the 32 
selection of the software tool, the characteristics and performance of the software, and the challenges of its 33 
implementation. As all the tested software only implement a single multi-criteria technique, the appropriate 34 
approach should be determined first because software packages rarely allow the choice of multiple MCDA 35 
methods [42]. In addition, some extra features of commercial software tools were not described because we 36 
did not have access to the full version. 37 
Our review focussed on MCDA software that were used in health care priority setting. However, there are 38 
many MCDA software that are used in other fields, which could prove useful for health care priority setting. 39 
For an overview of MCDA tools in other fields, and to assess their usefulness for healthcare, we point the 40 
readers towards the key studies that review MCDA software [18,46–49]. These include the study of Ishizaka 41 
et al. that provides an assessment of nine MCDA methods and illustrates each method with freely available 42 
software [18]; Li et al. identified a set of ten MCDA methods and proposed a framework for MCDA software 43 
selection [46]; Weistroffer et al. describe and categorise 69 MCDA software based on the type of the 44 
decision problem to be resolved, the decision context, and the technology platform required by the 45 
software [47]; 23 multi-criteria decision analysis software tools were analysed by Mustajoki et al. in terms of 46 
18 
 
their applicability to support environmental planning processes [48]; and finally, Baizyldayeva et al. 1 
compared 10 decision-making software packages and provide recommendations on implementing them in 2 
Kazakhstan [49]. 3 
5. Conclusions 4 
We found that the use of multi criteria software yields advantages for the development of prioritization 5 
processes in health care and offer the possibility of adopting different MCDA methods. They also allow the 6 
inclusion of several types of stakeholders with the ability to analyse a greater number of alternatives and/or 7 
criteria, and perform sensitivity analyses. However, this field is still developing with only a few studies that 8 
have implemented multi-criteria software in health care priority setting. There are software available but 9 
those that offer users more functionalities of analysis, visualization, and reports often require a license 10 
payment.  11 
6. Availability of data and materials.  12 
All data analysed or generated during this study are included in this article. 13 
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1 MeSH descriptor: [Software] explode all trees 3154 
2 tool* or program* or application*  1571104 
3 #1 or #2  1571103 
4 MeSH descriptor: [Delivery of Health Care] explode all trees 43273 
5 Health*  375049 




prioritization algorithm or "prioritization analysis" or 
"prioritization approach" or "prioritization based" or 
"prioritization capacity" or "prioritization criteria" or 
"prioritization decision making" or "prioritization decisions" or 
"prioritization efforts" or "prioritization framework" or 
"prioritization matrix" or "prioritization method" or 
"prioritization methodology" or "prioritization methods" or 
"prioritization procedure" or "prioritization process" or 
"prioritization processes" or "prioritization project" or 
"prioritization protocol" or "prioritization rule" or 
"prioritization scheme" or "prioritization schemes" or 
"prioritization skills" or "prioritization strategies" or 
"prioritization study" or "prioritization system" or 
"prioritization tool" or "prioritization tools" or "prioritizations" 
or "prioritized research agenda" or "prioritized selection" or 
"prioritized world agenda" or "priority setting"  170 
8 #3 and #6 and #7  34 
 
   
Econlit 1 Software or tool* or program* or application 343369 
 2 Priorit* OR Resource allocation 84345 
 3 Health* 159704 
 4 #3 AND #2 AND #1 593 
 
   
Embase 1 SOFTWARE/ 32145 
 
2 
(tool* or program* or application*).mp. [mp=title, abstract, 
original title, name of substance word, subject heading word, 
keyword heading word, protocol supplementary concept 
word, rare disease supplementary concept word, unique 
identifier, synonyms] 
2973371 
 3 1 or 2 3075578 
 4 "Delivery of Health Care"/ 170489 
 
5 
(Health or healthcare).mp. [mp=title, abstract, original title, 
name of substance word, subject heading word, keyword 
heading word, protocol supplementary concept word, rare 
disease supplementary concept word, unique identifier, 
synonyms] 
3725876 
 6 4 or 5 3725876 
 
7 
("prioritization algorithm" or "prioritization analysis" or 
"prioritization approach" or "prioritization based" or 
"prioritization capacity" or "prioritization criteria" or 
"prioritization decision making" or "prioritization decisions" or 
"prioritization efforts" or "prioritization framework" or 
"prioritization matrix" or "prioritization method" or 
"prioritization methodology" or "prioritization methods" or 
"prioritization procedure" or "prioritization process" or 
"prioritization processes" or "prioritization project" or 
"prioritization protocol" or "prioritization rule" or 
"prioritization scheme" or "prioritization schemes" or 
"prioritization skills" or "prioritization strategies" or 




"prioritization tool" or "prioritization tools" or "prioritizations" 
or "prioritized research agenda" or "prioritized selection" or 
"prioritized world agenda" or "priority setting").mp. [mp=title, 
abstract, original title, name of substance word, subject 
heading word, keyword heading word, protocol 
supplementary concept word, rare disease supplementary 
concept word, unique identifier, synonyms] 
 8 3 and 6 and 7 1114 
 
   
Medline 1 SOFTWARE/ 103406 
 
2 
(tool* or program* or application*).mp. [mp=title, abstract, 
original title, name of substance word, subject heading word, 
keyword heading word, protocol supplementary concept 
word, rare disease supplementary concept word, unique 
identifier, synonyms] 
2305919 
 3 1 or 2 2421801 
 4 "Delivery of Health Care"/ 85385 
 
5 
(Health or healthcare).mp. [mp=title, abstract, original title, 
name of substance word, subject heading word, keyword 
heading word, protocol supplementary concept word, rare 
disease supplementary concept word, unique identifier, 
synonyms] 
2654938 
 6 4 or 5 2654938 
 
7 
("prioritization algorithm" or "prioritization analysis" or 
"prioritization approach" or "prioritization based" or 
"prioritization capacity" or "prioritization criteria" or 
"prioritization decision making" or "prioritization decisions" or 
"prioritization efforts" or "prioritization framework" or 
"prioritization matrix" or "prioritization method" or 
"prioritization methodology" or "prioritization methods" or 
"prioritization procedure" or "prioritization process" or 
"prioritization processes" or "prioritization project" or 
"prioritization protocol" or "prioritization rule" or 
"prioritization scheme" or "prioritization schemes" or 
"prioritization skills" or "prioritization strategies" or 
"prioritization study" or "prioritization system" or 
"prioritization tool" or "prioritization tools" or "prioritizations" 
or "prioritized research agenda" or "prioritized selection" or 
"prioritized world agenda" or "priority setting").mp. [mp=title, 
abstract, original title, name of substance word, subject 
heading word, keyword heading word, protocol 
supplementary concept word, rare disease supplementary 
concept word, unique identifier, synonyms] 
3074 




Web of Science 1 TI=(Software or tool* or program* or application*) 3500827 
 2 TI=(Priorit* OR Resource allocation) 110568 
 3 TS=(Health*) 7401584 
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